Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis

Trial Profile

Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Oct 2017

At a glance

  • Drugs NPB 06 (Primary)
  • Indications Venous thrombosis
  • Focus Registrational; Therapeutic Use
  • Sponsors Nihon Pharmaceutical
  • Most Recent Events

    • 24 Oct 2017 Primary endpoint (The proportion of patients obtained complete recanalization or partial recanalization of portal vein thrombosis) has been met, according to results presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases.
    • 24 Oct 2017 Results presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases.
    • 07 Sep 2016 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top